BRIEF published on 07/26/2024 at 19:50, 1 year 6 months ago EMEIS: H1 2024 results and growth prospects Outlook For 2024 Turnover Asset Sales Occupancy Rate EBITDAR
PRESS RELEASE published on 07/26/2024 at 19:45, 1 year 6 months ago Inside Information / News release on accounts, results emeis Group reports 9.2% revenue growth in first-half 2024, with occupancy rates rising. EBITDAR at similar levels to H1 2023. 2024 outlook revised downwards due to operational challenges Revenue Growth 2024 Outlook EBITDAR Emeis Group Occupancy Rates
BRIEF published on 07/15/2024 at 18:52, 1 year 6 months ago EMEIS Signs €24 Million Real Estate Promissory Sales Agreement in Portugal Real Estate De-leveraging Capital Optimization Portugal EMEIS
PRESS RELEASE published on 07/15/2024 at 18:47, 1 year 6 months ago Inside Information / Operations of the issuer (acquisitions, sales...) emeis signs €24 million real estate sales agreement in Portugal, optimizing capital and reducing real estate portfolio. Transactions in multiple countries support capital allocation strategy Capital Optimization Real Estate Sales Portugal Asset Disposal EMEIS
Published on 01/30/2026 at 14:00, 2 hours 15 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 7 hours 40 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 8 hours 15 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 14 hours ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 16 hours 15 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 16:00, 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation
Published on 01/30/2026 at 15:57, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 18:00, 22 hours 15 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 22 hours 30 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 22 hours 30 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
